Neural Tissue Engineering


Neural tissue engineering offers tremendous promise to combat the effects of disease, aging, or injury in the nervous system. The Cullen Lab is developing tissue-engineering strategies to directly replace damaged or diseased neural tissue, or to augment the capacity for nervous system regeneration and restore lost function.  Our overall strategy is to engineer living three-dimensional (3-D) neural tissue that is “pre-engineered” outside the body with controlled neuroanatomical and functional characteristics, that upon delivery into the body will promote neuroregeneration or recreate lost neuroanatomy.  One application being investigated is developing constructs of axonal tracts that, upon transplantation, may facilitate nervous system repair by directly restoring lost connections or by serving as a targeted scaffold to promote host regeneration by exploiting axon-mediated axonal regeneration.

Three-dimensional constructs for neuroregeneration

Concept: Three-dimensional constructs for neuroregeneration.  (a-b) Tissue engineered constructs were “pre-engineered” in vitro to contain long axonal tracts, thus recapitulating the architecture of lost neural tissue to directly replace lost axonal tracts or to serve as living targeted scaffolds axonal regeneration. Constructs may be (a) unidirectional or (b) bidirectional depending on the application specific to trauma or disease condition.


Techniques to achieve longitudinal axonal extension and/or growth.  Confocal reconstructions of neuronal constructs achieved via (a) stretch-growth, (b) microconduit containment, or (c) along a microfiber. (a) Axon stretch-growth results in two neuronal populations spanned by long axonal tracts. (b) A dense cluster of neuronal somata was located at one end of the micro-conduits with axonal projections extending longitudinally projecting several millimeters in the interior (outer diameter denoted by dashed lines). (c) Preferential longitudinal growth along a conductive polymer micro-fiber. Neuronal survival and maintenance of architecture in engineered nervous tissue constructs




Neuronal survival and maintenance of architecture in engineered nervous tissue constructs.  Representative confocal reconstructions of transplanted GFP+ engineered nervous tissue constructs used to bridge an excised segment of sciatic nerve (6 weeks post-implantation).  (A) Continuous proximal (top) and distal portions (bottom) from a GFP+ construct immunolabeled for NF-200 (red) (scale bars = 0.5 mm).  Multiple transplanted ganglia were evident on the proximal and distal ends (arrow heads) with aligned axonal tracts spanning these neuronal populations.  Remnants of the PGA tube were observed bordering the transplant at this time-point (note arced border material autofluorescing red).  (B-C) Higher magnification regions from (A) rotated 90° (scale bars = 100 µm).  (B) Major bundles of neurites projected from the proximal ganglia across the constructs as well as into host nerve towards the spinal cord (white arrow).  (C) Similarly, neuritic bundles also projected from the distal ganglia across the constructs and distally into the distal nerve segment (yellow arrow).  (D-F) Increased magnification from specified regions; GFP+ (left column), NF-200+ (center column), with overlay (right column); scale bars = 20 µm.  (D) Central axonal tracts co-labeled for GFP and NF-200.  (E) Transplanted ganglia became dense, three-dimensional clusters of neurons.  (F) Neurites growing from the host into the proximal end of the constructs were observed as NF-200+ axons that were not co-localized with GFP (arrows).









Host axons growing along transplanted axons.  Axons from the surviving cluster of transplanted neurons at the graft interior (blown up region from above figure). Axons from the transplanted neuronal constructs are labeled green (GFP+) and transplant and host neurofilament-positive axons are immunostained red. These axons are a mix of the transplanted axons and host axons, suggesting that host axonal growth occurs via axon-mediated axon regeneration.














Neurobiological Investigation

In addition, advances in neural tissue engineering have resulted in the development and implementation of 3-D neural cellular constructs, which may serve as neurofidelic in vitro investigational platforms. Cells in the brain interact within a complex, multicellular environment with tightly-coupled 3-D cell-cell/cell-extracellular matrix interactions; yet most in vitro models utilize planar systems lacking in vivo-like ECM. As such, neural cultures with cells distributed throughout a thick (>500microns), bioactive extracellular matrix may provide a more physiologically-relevant setting to study neurobiological phenomena than traditional planar cultures. Dr. Cullen has pioneered the development of a range of 3-D neural cellular constructs and has applied these to increase our understanding of factors influencing neural cell survival, function, and network formation.


Tissue Engineered 3-D Neural Cell Cultures for Neurobiological Investigations In Vitro.  Cellular constructs consist of (a) neurons or (b) neurons mixed with astrocytes, distributed throughout the full thickness of a 3-D matrix/scaffold (>500 µm).  (c) Neurons in 3-D culture, shown to express neuronal-specific proteins MAP-2 (green) and tau-5 (red) with nuclear marker Hoechst 33258 (blue), assume complex morphologies with 3-D neurite extension. (d) These cultures are useful to study neuron-astrocyte interactions in 3-D. (e) Live neurons (green) demonstrating survival and network formation throughout the thickness of the 3-D cultures. (f) Volumetric rendering of live neurons in 3-D culture. Neurobiological studies of neural cells within 3-D matrices provide enhanced fidelity to in vivo while affording all advantages of traditional (planar) in vitro systems.










Z-stack of a 3-D neuronal culture

Neuronal network with synapses

Contact Information

D. Kacy Cullen, Ph.D
105E Hayden Hall, 3320 Smith Walk
Philadelphia, PA 19104

Apply to join the Cullen Lab



News and Events

  • Dr. John O’Donnell, a postdoctoral fellow in the Cullen Lab, was awarded a prestigious NRSA (F32) Training Fellowship through the NIH. His project is titled “Modeling Disorders of Consciousness”. Way to go John!
  • The Cullen Lab and collaborators had a poster selected as one of the "Blue Ribbon Highlights" at the International Congress of Parkinson's Disease and Movement Disorders in Vancouver, Canada. The poster was titled “Tissue Engineered Nigrostriatal Pathway for Treatment of Parkinson’s Disease”. A write-up about the project in Neurology Today can be found here.
  • Dr. Cullen and collaborators received a major 4-year Merit Review Award from the Department of Veterans Affairs to advance their project “Transplantable Micro-Tissue Engineered Neural Networks to Restore the Nigrostriatal Pathway in Parkinson's Disease”. This exciting project applies cutting-edge tissue engineering and regenerative medicine techniques to build the full nigrostriatal pathway in vitro using human induced pluripotent stem cells, with efficacy testing of these human-scale constructs in a large animal model of Parkinson’s disease. Success of this project over the next several years will enable clinical trials based on precision medicine– rebuilding complex brain networks using a patients own cells and implanting these fully preformed constructs to replace vulnerable pathways lost due to neurodegenerative disease. The co-investigators on this project are Dr. Isaac Chen, Dr. John Wolf, and Dr. John Duda. Way to go team!
  • Dr. Cullen was promoted to Associate Professor at the University of Pennsylvania. Congratulations Dr. Cullen!
  • Congratulations to Laura Struzyna, a Bioengineering Doctoral Candidate in the Cullen Lab, whose winning entry for Penn's "Art in Science" competition was featured on the NIH Director's Blog!
  • The Cullen Lab and collaborators at Penn (Drs. Isaac Chen, Douglas Smith, and John Wolf) and Rutgers University (Drs. Joachim Kohn and Hilton Kaplan) were awarded a 3-year, $2.1 million dollar grant from the U.S. Dept. of Defense on "Tissue Engineering Strategies to Maintain Distal Target Efficacy and Promote Full Functional Recovery Following Major Peripheral Nerve Injury".
  • The Cullen Lab and collaborators had two abstracts selected as “Hot Topics” (top 2% of submissions) for presentation in a platform session at the World Parkinson’s Congress meeting in Portland, OR. Carolyn Keating, a Neuroscience doctoral candidate, presented "Diffuse Brain Injury in Swine Causes Plasmalemmal Dysruption and α-Synuclein Over-Expression in the Substantia Nigra". Dr. John Duda presented "Can Living Micro-Tissue Engineered Axonal Tracts Reconstruct the Nigrostriatal Pathway in PD?"
  • Dr. Cullen had the honor of being selected as one of "3 People to Watch in Neuroscience in 2016" by STAT News (Health, Medicine, and Biotech publication):
  • Congratulations to Laura Struzyna, a Bioengineering Doctoral Candidate in the Cullen Lab, who won second place in the Perelman School of Medicine 2016 "Art in Science" Competition. The winning image is shown here.
  • Penn and the Journal of Neural Engineering put out a press release for our most recent manuscript describing the Cullen Lab's novel micro-tissue engineered neural networks to restore brain circuitry. Link:
  • Carla Winter, and undergraduate researcher in the Cullen Lab for the past 3 years, was selected as a George J. Mitchell Scholar (one of only 12 in the U.S.): is very prestigious and well-deserved honor. Way to go Carla!
  • Dr. Cullen had the honor of giving a TED-style talk at Penn’s Annual Neuroscience Public Lecture Series on Neuroengineering: Where Biology Meets Technology. Dr. Cullen discussed the lab’s pioneering work on "Restoring Nervous System Structure and Function With Tissue Engineered 'Living Scaffolds'” (YouTube video:
  • The Cullen Lab and collaborators Dr. John Wolf, Dr. Misha Serruya, Dr. Brain Litt, Dr. Reuben Kraft and Dr. Isaac Chen were awarded a 3-year, $2 million dollar cooperative agreement (U01) from the NIH to further pioneer "Biological 'Living Electrodes' Using Tissue Engineered Axonal Tracts to Probe and Modulate the CNS".
  • The Cullen Lab received a 2-year grant from the U.S. Dept. of Defense to advance "Novel Tissue-Engineered Nerve Grafts for Repair of Currently Untreatable Peripheral Nerve Injury".
  • Bioengineering Ph.D. Candidate, Kritika Katiyar, was selected for a prestigious NRSA F31 Graduate Research Fellowship through the National Institutes of Health based on her proposal for "Molecular Mediators of Axon-Facilitated Axon Regeneration."
  • Dayo Adewole, a Bioengineering Ph.D. student in the Cullen Lab, was awarded a 3-year Graduate Research Fellowship through the National Science Foundation to develop next-generation neuroprosthetic interfaces. Way to go Dayo!
  • The Cullen Lab and collaborators Dr. John Duda, Dr. Isaac Chen, and Dr. John Wolf were awarded a 2-year grant from the Michael J. Fox Foundation for the project "Restoring the Nigrostriatal Pathway with Living Micro-Tissue Engineered Axonal Tracts".

View more news. →